TABLE 1.
Whole blood cytokine production in response to 24-h LPS treatment at the beginning and end of a 1-y vitamin E supplementation trial in elderly nursing home residents1
Cytokine | LPS | Group | n | Baseline | Follow-up |
---|---|---|---|---|---|
IL-1β | mg/L | ng/L | |||
1.0 | Vitamin E | 47 | 545 ± 384 | 461 ± 377* | |
Placebo | 63 | 547 ± 290 | 426 ± 232* | ||
0.01 | Vitamin E | 47 | 287 ± 231 | 254 ± 204 | |
Placebo | 63 | 276 ± 179 | 237 ± 166 | ||
IL-6 | |||||
1.0 | Vitamin E | 47 | 8780 ± 5720 | 7787 ± 4319* | |
Placebo | 63 | 9045 ± 4812 | 7600 ± 4182* | ||
0.01 | Vitamin E | 47 | 5367 ± 3542 | 5084 ± 2569 | |
Placebo | 63 | 5596 ± 2883 | 5059 ± 3051 | ||
TNFα | |||||
1.0 | Vitamin E | 44 | 1476 ± 1884 | 769 ± 766* | |
Placebo | 61 | 1211 ± 1002 | 685 ± 638* | ||
0.01 | Vitamin E | 36 | 419 ± 464 | 389 ± 496 | |
Placebo | 55 | 346 ± 317 | 329 ± 422 |
Data are unadjusted means ± SD. *Different from baseline, P < 0.05 (Student's t test of log-transformed data).